AzTrials
AzTrials

Abdominal DiastasisNCT05731479

Radiofrequency Diathermy and Therapeutic Exercise Protocol in Women With Abdominal Diastasis

A study testing Diathermy + exercise group in people with Abdominal Diastasis, run by University of Valencia at 1 site in Spain.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Diastasis recti abdominis (DRA) is defined as the presence of divergence between the rectus abdominis muscles along the linea alba. DRA is associated with decreased abdominal strength and degraded health and physical functioning, which results in poorer body perception and satisfaction and negatively affects the… Read more about this study

Who is it for?
Ages 18 to 45 years, women only
Conditions the study is for
Abdominal Diastasis
What is being tested?
Diathermy + exercise group
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
34 participants
Where
1 siteSpain
Study dates
16 Jan 2023to 30 Oct 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • Women only
  • No healthy volunteers
  • Adult

Who may be able to join

  • Women aged 18 to 45 years,
  • 3 to 24 months postpartum
  • Criteria of abdominal diastasis according to Beer's criteria (Beer et al.2009)

Who cannot join

  • Rejection to sign the informed consent form
  • Presence of any metabolic, neurological or connective tissue disease, as well as cognitive alterations.

Trial locations and contacts

1 site in 1 country.

Spain1 site
  • Faculty of Physiotherapy. University of Valencia

    Valencia, Valencia, 46002

Other trials in Spain

About this study

Official title: Effectiveness of a Radiofrequency Diathermy and Therapeutic Exercise Protocol in Women With Abdominal Diastasis. Randomized Controlled Trial

Diastasis recti abdominis (DRA) is defined as the presence of divergence between the rectus abdominis muscles along the linea alba. DRA is associated with decreased abdominal strength and degraded health and physical functioning, which results in poorer body perception and satisfaction and negatively affects the quality of life in its multiple spheres (social, sexual and personal). Regarding the different treatment techniques for DRA, different treatments have been described, such as bandages, electrotherapy or therapeutic exercise, the latter being the most scientifically supported option to approach DRA conservatively. Exercise has shown positive effects on DRA severity, abdominal muscle thickness, abdominal strength and endurance, and quality of life in women with DRA.

Another treatment that has shown promising effects in various pathologies is radiofrequency diathermy using the Capacitive-Resistive Electrical Transfer system. The capacitive mode acts on soft tissues containing electrolytes such as muscles and vascular and lymphatic tissues. On the other hand, the resistive mode acts on tissues of higher density and fat and fiber content, such as bones, ligaments and tendons. It has been documented that this type of therapy acts favoring the vascularization of tissues, decreasing inflammation and favoring the processes of cellular repair and analgesia. Its beneficial effect on low back pain and various pelvic floor disorders has been studied. However, at present, there are no studies evaluating the effectiveness of this type of intervention in people with abdominal diastasis.

In view of the above, the objective of our study is to evaluate the effectiveness of a protocol based on therapeutic exercise preceded by a radiofrequency diathermy program on anthropometric parameters, anatomo-physiological parameters, functional parameters, and parameters related to psychological aspects in women with postpartum abdominal diastasis.

Read the detailed description

A longitudinal randomized controlled experimental study will be carried out. The sample will be composed of 34 postpartum women, randomly distributed in two groups: i) diathermy + exercise group (GDE) (n=17), and ii) placebo diathermy + exercise group (GPE) (n=17).

The evaluations will be performed at two time points: i) before the intervention (T1), and ii) after the last session (T2).

Being tested
Diathermy + exercise group, Diathermy placebo + exercise group

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Diathermy + exercise groupOther

    The Diathermy + Exercise group will receive diathermy for 15 minutes, of which 5 minutes will be applied in the capacitive method and 10 minutes in the resistive method. You will then perform 20 minutes of the following exercises: 1) Bird-Dog, 2) Crunch, 3) Obliques, 4) Drawing, 5) Half plank and 6) Side-plank. You will perform 8-12 repetitions and 3 sets of each exercise. 3 sessions of 35 minutes per week for 8 weeks.

  • Diathermy placebo + exercise groupOther

    The Placebo + Exercise group will receive 15 minutes of application of the diathermy device without energy emission. It will then perform the same therapeutic exercise protocol described in the GDE. 3 sessions of 35 minutes per week for 8 weeks.

Study groups in NCT05731479
Study groupRoleWhat they receive
Diathermy + exercise groupExperimentalApplication of diathermy and a therapeutic exercise protocol.
Receives: Other: Diathermy + exercise group
Diathermy placebo + exercise groupPlacebo comparatorApplication of the diathermy device without energy emission and a therapeutic exercise protocol.
Receives: Other: Diathermy placebo + exercise group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Rectus abdominis distance

    The distance between rectus abdominis in millimetres (mm) will be assessed with an ultrasound machine, using a high-resolution linear array transducer.

    Measured: Baseline

  2. Rectus abdominis distance

    The distance between rectus abdominis in millimetres (mm) will be assessed with an ultrasound machine, using a high-resolution linear array transducer.

    Measured: Immediately after the intervention

  3. Rectus abdominis thickness

    The rectus abdominis thickness in millimetres (mm) will be assessed with an ultrasound machine, using a high-resolution linear array transducer.

    Measured: Baseline

  4. Rectus abdominis thickness

    The rectus abdominis thickness in millimetres (mm) will be assessed with an ultrasound machine, using a high-resolution linear array transducer.

    Measured: Immediately after the intervention

Secondary outcomes (20)
  1. Body composition

    Body composition by means of Bioimpedance (Tanita DC-430MA, Tanita Corporation of America, Inc., Arlington Heights, IL, USA).

    Measured: Baseline

  2. Body composition

    Body composition by means of Bioimpedance (Tanita DC-430MA, Tanita Corporation of America, Inc., Arlington Heights, IL, USA).

    Measured: Immediately after the intervention

  3. Strength of the abdominal flexor musculature

    Strength of the abdominal flexor musculature by means of a dynamometer (Lafayette, Indiana, USA)

    Measured: Baseline

  4. Strength of the abdominal flexor musculature

    Strength of the abdominal flexor musculature by means of a dynamometer (Lafayette, Indiana, USA)

    Measured: Immediately after the intervention

  5. Kinesiophobia

    Kinesiophobia with the Tampa Scale of Kinesiophobia-11 questionnaire: It maintains items 1, 2, 3, 5, 6, 7, 10, 11, 13, 15, and 17 from the original 17-point scale, and its score ranges from 11-44, where the lowest 11 means no or negligible kinesiophobia, and the higher scores indicate an increasing degree of kinesiophobia

    Measured: Baseline

  6. Kinesiophobia

    Kinesiophobia with the Tampa Scale of Kinesiophobia-11 questionnaire: It maintains items 1, 2, 3, 5, 6, 7, 10, 11, 13, 15, and 17 from the original 17-point scale, and its score ranges from 11-44, where the lowest 11 means no or negligible kinesiophobia, and the higher scores indicate an increasing degree of kinesiophobia

    Measured: Immediately after the intervention

  7. Body image

    Body image using the Multidimensional Body Self Relations Questionnaire: It consists of 69 items each rated on a 5-point scale from 1 to 5 (strongly disagree-strongly agree). The higher the score, the greater the satisfaction with one's own body image, so the total score of the instrument requires reversing the score of the items that indicate dissatisfaction

    Measured: Baseline

  8. Body image

    Body image using the Multidimensional Body Self Relations Questionnaire: It consists of 69 items each rated on a 5-point scale from 1 to 5 (strongly disagree-strongly agree). The higher the score, the greater the satisfaction with one's own body image, so the total score of the instrument requires reversing the score of the items that indicate dissatisfaction

    Measured: Immediately after the intervention

  9. Perception of change after the intervention

    Perception of change after the intervention with the Patient Perception of Change after Treatment questionnaire. consisting of a verbal scale, with 7 points "very much improved", "much improved", "minimally improved", "no change", "minimally worse", "much worse", "very much worse".

    Measured: Baseline

  10. Perception of change after the intervention

    Perception of change after the intervention with the Patient Perception of Change after Treatment questionnaire. consisting of a verbal scale, with 7 points "very much improved", "much improved", "minimally improved", "no change", "minimally worse", "much worse", "very much worse".

    Measured: Immediately after the intervention

  11. Linea alba thickness

    Linea alba thickness in millimetres (mm) will be assessed with an ultrasound machine, using a high-resolution linear array transducer.

    Measured: Baseline

  12. Linea alba thickness

    Linea alba thickness in millimetres (mm) will be assessed with an ultrasound machine, using a high-resolution linear array transducer.

    Measured: Immediately after the intervention

  13. Linea alba distortion index

    Linea alba distortion index in millimetres (mm) will be assessed with an ultrasound machine, using a high-resolution linear array transducer.

    Measured: Baseline

  14. Linea alba distortion index

    Linea alba distortion index in millimetres (mm) will be assessed with an ultrasound machine, using a high-resolution linear array transducer.

    Measured: Immediately after the intervention

  15. Stabilization capacity and resistance of the abdomino-lumbo-pelvic capsule

    Stabilization capacity and resistance of the abdomino-lumbo-pelvic capsule, with a battery of validated maneuvers: gluteal bridge, gluteal bridge with unipodal support, lateral planks and horizontal plank.

    The measurement unit is the second (s) for all maneuvers, and the time for each manoeuvre shall be averaged.

    Measured: Baseline

  16. Stabilization capacity and resistance of the abdomino-lumbo-pelvic capsule

    Stabilization capacity and resistance of the abdomino-lumbo-pelvic capsule, with a battery of validated maneuvers: gluteal bridge, gluteal bridge with unipodal support, lateral planks and horizontal plank.

    The measurement unit is the second (s) for all maneuvers, and the time for each manoeuvre shall be averaged.

    Measured: Immediately after the intervention

  17. Abdominal circumference

    Abdominal circumference will be assessed by means of tape measure in centimetres (cm). Two measurements shall be taken and averaged.

    Measured: Baseline

  18. Abdominal circumference

    Abdominal circumference will be assessed by means of tape measure in centimetres (cm). Two measurements shall be taken and averaged.

    Measured: Immediately after the intervention

  19. Abdominal fold

    Abdominal fold will be assessed by means of a plicometer in milimetres (mm). Two measurements shall be taken and averaged.

    Measured: Baseline

  20. Abdominal fold

    Abdominal fold will be assessed by means of a plicometer in milimetres (mm). Two measurements shall be taken and averaged.

    Measured: Immediately after the intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Feb 2023
  2. Study start16 Jan 2023
  3. Primary completion30 Sep 2025
  4. Study completion30 Oct 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
34 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05731479
Sponsor's protocol ID
2524988
Status last verified
Jun 2026
First submitted
26 Jan 2023
Last updated
25 Jun 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Gluppe SB, Engh ME, Bo K. Immediate Effect of Abdominal and Pelvic Floor Muscle Exercises on Interrecti Distance in Women With Diastasis Recti Abdominis Who Were Parous. Phys Ther. 2020 Aug 12;100(8):1372-1383. doi: 10.1093/ptj/pzaa070.

    PubMed 32302393
  • Keshwani N, Mathur S, McLean L. The impact of exercise therapy and abdominal binding in the management of diastasis recti abdominis in the early post-partum period: a pilot randomized controlled trial. Physiother Theory Pract. 2021 Sep;37(9):1018-1033. doi: 10.1080/09593985.2019.1675207. Epub 2019 Oct 23.

    PubMed 31642725
  • Thabet AA, Alshehri MA. Efficacy of deep core stability exercise program in postpartum women with diastasis recti abdominis: a randomised controlled trial. J Musculoskelet Neuronal Interact. 2019 Mar 1;19(1):62-68.

    PubMed 30839304

Questions about this trial

What is this clinical trial studying?

A study testing Diathermy + exercise group in people with Abdominal Diastasis, run by University of Valencia at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 25 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Rectus abdominis distance (time frame: Baseline). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05731479, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Jun 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in